series-b
Stage
2
Investors
About
Rivus Pharmaceuticals develops oral medicines to treat cardiometabolic health conditions, focusing on therapies for chronic liver disease (MASH) and obesity.
Explore Rivus Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.